Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

ConditionsRetinopathy of Prematurity Both Eyes Retinal Disease Persistent Fetal Vasculature Coats Disease Coats Retinopathy Familial Exudative Vitreoretinopathies Vitreous Disorder Vitreous Anomalies Retinal Vascular Disorder

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age0-18

SponsorChang Gung Memorial Hospital

About this trial

This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.

Eligibility criteria

Qualifiers

Patients less than 18 years old

Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.

Disqualifiers

Patients who cannot cooperate fully with detailed ophthalmic examinations.

Trial design

Treatments tested in this trial

Pars plana vitrectomy with a 18 mm short vitrector

Treatment groups

60 Participants

are divided into 1 treatment group

Sponsors and collaborators

Chang Gung Memorial Hospital

Lead sponsor

Source ClinicalTrials.gov